Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Leukaemia Foundation joins forces with blood cancer survivor Briony Benjamin to raise awareness of lymphoma

Leukaemia Foundation 3 mins read

On World Lymphoma Awareness Day (September 15), the Leukaemia Foundation is joining forces with Gold Coast author, content creator, motivational speaker and inspiring lymphoma survivor, Briony Benjamin.   

As a national ambassador for the Leukaemia Foundation, Briony is hoping to raise much-needed awareness of lymphoma - the most diagnosed form of blood cancer in Australia – and is encouraging anyone impacted by the disease to reach out to the Leukaemia Foundation for support.   

With over 65,200 Australians currently living with lymphomai, World Lymphoma Awareness Day provides an opportunity for the Leukaemia Foundation to educate people on the signs and symptoms of the disease, which can often be subtle and difficult to recognise.  

Common lymphoma symptoms include painless lumps around the lymph nodes usually in the neck, armpit or groin that may be dismissed as harmless. Other symptoms are night sweats, recurrent infections or fevers, and even itchy skin. 

As someone who was misdiagnosed several times before eventually being told she had lymphoma, Briony believes that because the disease can be difficult to spot, it’s especially important to listen to your body and to act when something doesn’t feel right. 

The Leukaemia Foundation encourages Australians to speak to your GP if you have ongoing symptoms that can’t be explained. The sooner that a blood cancer diagnosis occurs, the greater chance people have of beating the disease. 

Anyone impacted by lymphoma, or any type of blood cancer can contact Australia’s blood cancer support line Monday to Friday via calling 1800 620 420 or visit bloodcancer.org.au.   

AVAILABLE FOR INTERVIEW - BRIONY BENJAMIN: 

  • Briony is a Gold Coast based storyteller, content creator, motivational speaker and author of the book and journal ‘Life is Tough But So Are You’.  

  • Briony was a healthy and fit 31-year-old before she was diagnosed with stage four Hodgkin lymphoma in 2018, a shock diagnosis which instantly turned her life upside down. 

  • Briony was thrown into life-saving treatment almost immediately including months of grueling chemotherapy where she lost her hair. 

  • After eventually being declared cancer-free, it took Briony a long time to recover physically and emotionally from her blood cancer experience.  

  • She is now a healthy and thriving blood cancer survivor and is pregnant with her first child due in October. 

  • Briony is available for interviews to speak about her own first-hand experience with lymphoma and what she hopes to achieve in collaboration with Leukaemia Foundation on World Lymphoma Awareness Day.  

Please contact the Leukaemia Foundation media team to interview Briony Benjamin, and/or a Leukaemia Foundation spokesperson at [email protected]. 

Lymphoma – facts and figuresii: 

  • Lymphoma is the most common type of blood cancer in Australia. 

  • In 2023, 7,403 Australians will be diagnosed with lymphoma. This is projected to more than double to reach 17,171 people per year by 2035.  

  • Currently, 65,233 Australians are living with lymphoma.  

 


About us:

About the Leukaemia Foundation: The Leukaemia Foundation has been named Australia's most reputable cancer charity and third most reputable charity overall. We stand with Australia to help cure and conquer blood cancer – with care. Together we are attacking every blood cancer, from every direction, in every way we can. We stand beside every Australian to be their voice and their someone-to-turn to, fighting to get them access to the best care. We also accelerate research that is delivering rapid advancements in blood cancer diagnosis and treatments. Plus, we provide services and support that empower people living with any blood cancer to live well after diagnosis. You can learn more about the Leukaemia Foundation and blood cancer at leukaemia.org.au 


Contact details:

Please contact the Leukaemia Foundation media team to interview Briony Benjamin, and/or a Leukaemia Foundation spokesperson at [email protected]. 

Media

More from this category

  • Medical Health Aged Care
  • 18/05/2025
  • 08:48
Monash University

How AI can improve dementia detection

Researchers from the National Centre for Healthy Ageing (NCHA), a partnership between Monash University and Peninsula Health, have developed a novel method for improving dementia detection in hospitals by combining traditional methods with artificial intelligence (AI). Approximately 50 million people worldwide live with dementia, a number expected to triple by 2050, according to the World Alzheimer Report. In Australia, there is still a need to substantially improve our methods for counting people with dementia. Accurate Identification is critical to understanding the true size of the problem nationally, and to be able to effectively plan services. However, routine health data that…

  • Medical Health Aged Care
  • 18/05/2025
  • 05:30
Dementia Australia

Join us today for the Melbourne Memory Walk & Jog

What: Dementia Australia’s Melbourne Memory Walk & Jog    When: Sunday, 18 May from 7:30am   Who: More than 2,300 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Special guests Woody Whitelaw and Takaya Honda.   Where: Princes Park, Carlton North.   Dementia Australia spokespeople and local residents are available for interview. Photos and video of previous Memory Walk & Jog events for publication are available for use. For more information visit: https://www.memorywalk.com.au/event/melbourne/home Dementia Australia is the source of trusted information, education and services for the estimated more than 433,300 Australians living with…

  • Contains:
  • Medical Health Aged Care
  • 17/05/2025
  • 17:11
FUJIREBIO

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ ß-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

—First Blood-Based In-Vitro Diagnostic Test to Receive FDA Clearancefor Patients Being Assessed for Alzheimer’s Disease. — —Availability of Accurate, Accessible, Blood-Based Diagnostic Tests Will…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.